Skip to main content

Ultra-rapid Microbial Detection in Cell & Gene Therapy Products: the Closest you can be to Real-time Release 

Ultra-rapid microbial detection in cell & gene therapy products

Originally published in Cell and Gene Therapy Insights

When innovators are focused on shortening manufacturing process to meet patient demand for life saving therapies, there is a need for new quality control analytical method solutions that are fast enough to keep pace with faster manufacturing approaches. Watch the video or read the poster to know more about a new ultra-fast sterility solution for cell and gene therapeutic products.

You can find out more about:

  • Same-day sterility results for cell-based products (<6h time-to-result)
  • Sensitivity that is equivalent to compendial methods
  • Low testing volume (0.1–2 mL sample)
  • Detection of microorganisms in a product containing a very high concentration of mammalian cells (106–107 cell/mL)

DOWNLOAD THE POSTER

Filename
Ultra-rapid microbial detection in cell and gene therapy products the closest you can be to real-time release - Poster.pdf
Size
383 KB
Format
application/pdf

Related Content

SCANRDI®

SCANRDI® is a rapid, proprietary microbiological solution combining universal cell labeling and solid-phase cytometry with the ability to detect bacteria, yeasts, molds – both in vegetative and sporulated forms - and yeasts. 

Learn More
Non Growth based

Non-Growth-Based Alternative Sterility Testing

The SCANRDI® is a non-growth-based rapid microbial method (RMM) that detects not only viable microbial cells that can be isolated using a broth or agar plate but also viable but non-culturable (VBNC) microorganisms, including stressed and fastidious microorganisms that may not be recovered by standard culture methods, making SCANRDI® more sensitive than growth-based methods.
Read Article
Image Ultra Rapid Microbial Detection in Cell and Gene Therapy Products

Ultra Rapid Microbial Detection in Cell and Gene Therapy Products

The SCANRDI® is an ultra-rapid alternative technology for detecting microbial contaminants in drug products. Designed to meet compendial testing standards, studies on Limit of Detection (LoD) and Equivalency have been performed with a focus on species listed by the Pharmacopeias microorganisms.  

Read Article